1. Costs and Cost-Effectiveness of Biomedical, Non-Surgical HIV Prevention Interventions: A Systematic Literature Review

   • Fiammetta M. Bozzani
   • Fern Terris-Prestholt
   • Sergio Torres-Rueda

   Systematic Review Open access 19 December 2022 Pages: 467 - 480

   

2. Accounting for Adverse Events Following Immunization in Economic Evaluation: Systematic Review of Economic Evaluations of Pediatric Vaccines Against Pneumococcus, Rotavirus, Human Papillomavirus, Meningococcus and Measles-Mumps-Rubella-Varicella

   • Kris Doggen
   • Albert Jan van Hoek
   • Jeroen Luyten

   Systematic Review 21 February 2023 Pages: 481 - 497

   

3. Economic Analyses of Obsessive-Compulsive Disorder Interventions: A Systematic Review

   • Emily R. Strouphauer
   • Olivia J. Morris
   • Eric A. Storch

   Systematic Review 25 February 2023 Pages: 499 - 527

   

4. HTA Barriers for Conditional Approval Drugs

   • Mackenzie Mills

   Original Research Article 23 February 2023 Pages: 529 - 545

   

5. Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK

   • Junwen Zhou
   • Runguo Wu
   • Borislava Mihaylova

   Original Research Article Open access 23 February 2023 Pages: 547 - 559

   

6. How to Predict Drug Expenditure: A Markov Model Approach with Risk Classes

   • Valeska Hofbauer-Milan
   • Stefan Fetzer
   • Christian Hagist

   Original Research Article Open access 25 February 2023 Pages: 561 - 572

   

7. The Cost of Uncontrolled Blood Pressure in Australian General Practice: A Modelling Study Using Electronic Health Records (MedicineInsight)

   • Jacqueline Roseleur
   • David A. Gonzalez-Chica
   • Jonathan Karnon

   Original Research Article Open access 04 March 2023 Pages: 573 - 587

   

8. Cost-Effectiveness Analysis of Tofacitinib Compared with Biologics in Biologic-Naïve Patients with Moderate-to-Severe Ulcerative Colitis in Japan

   • Taku Kobayashi
   • Masato Hoshi
   • Toshifumi Hibi

   Original Research Article Open access 08 March 2023 Pages: 589 - 604

   

9. Correction to: Cost-Effectiveness Analysis of Molnupiravir Versus Best Supportive Care for the Treatment of Outpatient COVID-19 in Adults in the US

   • Hardik Goswami
   • Adnan Alsumali
   • Amy Puenpatom

   Correction Open access 16 March 2023 Pages: 605 - 605